All Stories

  1. Validation of a new Japanese classification for predicting severe bronchopulmonary dysplasia in preterm infants

    Article • Clinical and Experimental Pediatrics, March 2026, Korean Pediatric Society (KAMJE)

    Professor Fumihiko Namba

  2. Association of Bach1 Gene Polymorphisms with Susceptibility to Bronchopulmonary Dysplasia in Preterm Infants

    Article • Biomedicines, December 2025, MDPI AG

    Professor Fumihiko Namba

  3. Association of hyperglycemia in extremely preterm infants with neurodevelopmental outcomes at 18 months of corrected age

    Article • Perinatal Journal, August 2025, Springer Science + Business Media

    Professor Fumihiko Namba

  4. Variability in Home Oxygen Therapy Practices for Bronchopulmonary Dysplasia in Japan: A Questionnaire Survey

    Article • Journal of Paediatrics and Child Health, July 2025, Wiley

    Professor Fumihiko Namba

  5. Perinatal Risk Factors and Lung Function at 8 Years of Age in Extremely Preterm Infants: Insights from a New Japanese Bronchopulmonary Dysplasia Classification

    Article • Pediatrics & Neonatology, June 2025, Elsevier

    Professor Fumihiko Namba

  6. Impact of Home Oxygen Therapy for Bronchopulmonary Dysplasia on Families With Neonates: A Survey Conducted in Japan

    Article • Pediatric Pulmonology, June 2025, Wiley

    Professor Fumihiko Namba

  7. Shifting Paradigms in Bronchopulmonary Dysplasia: From Treatment to Etiology/Pathophysiology-Based Classification

    Article • Biomedicines, April 2025, MDPI AG

    Professor Fumihiko Namba

  8. Validation of a New Classification for Severe Bronchopulmonary Dysplasia in Extremely Preterm Infants: Insights from a Large Japanese Cohort

    Article • Neonatology, January 2025, Karger Publishers

    Professor Fumihiko Namba

  9. Early Transpyloric Tube Feeding in Preventing Adverse Respiratory Events in Extremely Low Birth Weight Infants

    Article • Biomedicines, December 2024, MDPI AG

    Professor Fumihiko Namba

  10. Early Transpyloric Tube Feeding in Preventing Adverse Respiratory Events in Extremely Low Birth Weight Infants

    Article • November 2024, MDPI AG

    Professor Fumihiko Namba

  11. Genetic Ablation of Pyruvate Dehydrogenase Kinase Isoform 4 Gene Enhances Recovery from Hyperoxic Lung Injury: Insights into Antioxidant and Inflammatory Mechanisms

    Article • Biomedicines, March 2024, MDPI AG

    Professor Fumihiko Namba

  12. Management of bronchopulmonary dysplasia in Japan: A nationwide survey

    Article • Early Human Development, November 2023, Elsevier

    Professor Fumihiko Namba

  13. Interventions for treating umbilical granuloma: a protocol for a systematic review and meta-analysis of randomised controlled trials

    Article • BMJ Open, October 2023, BMJ

    Professor Fumihiko Namba

  14. Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review

    Article • BMJ Open, September 2023, BMJ

    Professor Fumihiko Namba

  15. School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants

    Article • Children, July 2023, MDPI AG

    Professor Fumihiko Namba

  16. Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan

    Article • Perinatal Journal, July 2023, Springer Science + Business Media

    Professor Fumihiko Namba

  17. Correction To: Increased expression of heme oxygenase-1 suppresses airway branching morphogenesis in fetal mouse lungs exposed to inflammation

    Article • Pediatric Research, June 2023, Springer Science + Business Media

    Professor Fumihiko Namba

  18. iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants

    Article • BMJ Open, March 2023, BMJ

    Professor Fumihiko Namba

  19. Management and outcomes of periviable neonates born at 22 weeks of gestation: a single-center experience in Japan

    Article • February 2023, Research Square

    Professor Fumihiko Namba

  20. Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors

    Article • Biomedicines, February 2023, MDPI AG

    Professor Fumihiko Namba

  21. Burden of Treatments for Respiratory Complications in Extremely Premature Infants: Interviews with Caregivers

    Article • Biomedicine Hub, January 2023, Karger Publishers

    Professor Fumihiko Namba

  22. Therapeutic response of iNO in preterm infants with hypoxemic respiratory failure

    Article • Pediatrics International, January 2023, Wiley

    Professor Fumihiko Namba

  23. Effect of Fentanyl for Preterm Infants on Mechanical Ventilation: A Systematic Review and Meta-Analysis

    Article • Neonatology, January 2023, Karger Publishers

    Professor Fumihiko Namba, Farhad Shokraneh

  24. Oxidative and Inflammatory Markers Are Higher in Full-Term Newborns Suffering Funisitis, and Higher Oxidative Markers Are Associated with Admission

    Article • Children, May 2022, MDPI AG

    Professor Fumihiko Namba

  25. Thioredoxin-1 Ameliorates Oxygen-Induced Retinopathy in Newborn Mice through Modulation of Proinflammatory and Angiogenic Factors

    Article • Antioxidants, April 2022, MDPI AG

    Professor Fumihiko Namba

  26. Cytomegalovirus‐related sepsis‐like syndrome in very premature infants in Japan

    Article • Pediatrics International, January 2022, Wiley

    Professor Fumihiko Namba

  27. Is ibuprofen superior to indomethacin for patent ductus arteriosus in Japanese preterm infants?

    Article • Pediatrics International, May 2021, Wiley

    Professor Fumihiko Namba

  28. An experimental animal model of bronchopulmonary dysplasia: Secondary publication

    Article • Pediatrics International, May 2021, Wiley

    Professor Fumihiko Namba

  29. Severe Consumptive Coagulopathy in an Extremely-Low-Birth-Weight Infant with Intra-Abdominal Umbilical Vein Varix: A Case Report

    Article • American Journal of Perinatology Reports, April 2021, Thieme Publishing Group

    Professor Fumihiko Namba

  30. Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan

    Article • JMIR Research Protocols, March 2021, JMIR Publications Inc.

    Professor Fumihiko Namba

  31. Impact of being large-for-gestational-age on neonatal mortality and morbidities in extremely premature infants

    Article • Pediatric Research, January 2021, Springer Science + Business Media

    Professor Fumihiko Namba

  32. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates

    Article • Cochrane Database of Systematic Reviews, October 2020, Wiley

    Professor Fumihiko Namba

  33. Umbilical cord milking versus delayed cord clamping in term infants: a systematic review and meta-analysis

    Article • Perinatal Journal, September 2020, Springer Science + Business Media

    Professor Fumihiko Namba

  34. Difference in pyruvic acid metabolism between neonatal and adult mouse lungs exposed to hyperoxia

    Article • PLOS One, September 2020, PLOS

    Professor Fumihiko Namba

  35. Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan (Preprint)

    Article • July 2020, JMIR Publications Inc.

    Professor Fumihiko Namba

  36. Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, May 2020, Taylor & Francis

    Professor Fumihiko Namba

  37. Attenuation of Hyperoxic Lung Injury in Newborn Thioredoxin-1-Overexpressing Mice through the Suppression of Proinflammatory Cytokine mRNA Expression

    Article • Biomedicines, March 2020, MDPI AG

    Professor Fumihiko Namba

  38. Increased expression of heme oxygenase-1 suppresses airway branching morphogenesis in fetal mouse lungs exposed to inflammation

    Article • Pediatric Research, October 2019, Springer Science + Business Media

    Professor Fumihiko Namba

  39. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia

    Article • Pediatrics International, October 2019, Wiley

    Professor Fumihiko Namba

  40. Perinatal factors associated with bubbly/cystic appearance in bronchopulmonary dysplasia: A nationwide, population-based cohort study in Japan

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, June 2019, Taylor & Francis

    Professor Fumihiko Namba, Machiko Morita

  41. Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis

    Article • PLOS One, November 2018, PLOS

    Professor Fumihiko Namba

  42. Benefits of umbilical cord milking versus delayed cord clamping on neonatal outcomes in preterm infants: A systematic review and meta-analysis

    Article • PLOS One, August 2018, PLOS

    Professor Fumihiko Namba

  43. An in vitro evaluation of the influence of neonatal endotracheal tube diameter and length on the work of breathing

    Article • Pediatric Anesthesia, April 2018, Wiley

    Professor Fumihiko Namba

  44. Role of sex in morbidity and mortality of very premature neonates

    Article • Pediatrics International, July 2017, Wiley

    Professor Fumihiko Namba

  45. Bubbly and cystic appearance in chronic lung disease: Is this diagnosed as Wilson–Mikity syndrome?

    Article • Pediatrics International, March 2016, Wiley

    Professor Fumihiko Namba

  46. Sex-related differences in long-term pulmonary outcomes of neonatal hyperoxia in mice

    Article • Experimental Lung Research, February 2016, Taylor & Francis

    Professor Fumihiko Namba

  47. Generation Of Mice With Lung-Specific Expression Of Nuclear Heme Oxygenase-1

    Article • May 2011, American Thoracic Society

    Professor Fumihiko Namba

  48. Generation of Mice with Lung-specific Expression of Nuclear Heme oxygenase-1

    Article • Free Radical Biology and Medicine, January 2010, Elsevier

    Professor Fumihiko Namba

  49. Utility of a new transcutaneous jaundice device with two optical paths in premature infants

    Article • Pediatrics International, June 2007, Wiley

    Professor Fumihiko Namba